Search

Your search keyword '"Bogoviku, Jurgen"' showing total 9 results
Start Over Author "Bogoviku, Jurgen"
9 results on '"Bogoviku, Jurgen"'

3. The Jena Method: Perfusionist Independent, Standby Wet-Primed Extracorporeal Membrane Oxygenation (ECMO) Circuit for Immediate Catheterization Laboratory and/or Hybrid Operating Room Deployment.

Author

Haertel, Franz, Kaluza, Mirko, Bogoviku, Jurgen, Westphal, Julian, Fritzenwanger, Michael, Pfeifer, Ruediger, Kretzschmar, Daniel, Doenst, Torsten, Moebius-Winkler, Sven, and Schulze, P. Christian

Subjects
EXTRACORPOREAL membrane oxygenation, OPERATING rooms, CATHETERIZATION, OXYGENATORS
Abstract

Background: The timely initiation of extracorporeal membrane oxygenation (ECMO) is crucial for providing life support. However, delays can occur when perfusionists are not readily available. The Jena Method aims to address this issue by offering a wet-primed ECMO system that can be rapidly established without the perfusionist's presence. Methods: The goal was to ensure prompt ECMO initiation while maintaining patient safety. The method focuses on meeting hygienic standards, safe primed storage of the circuit, staff training, and providing clear step-by-step instructions for the ECMO unit. Results: Since implementing the Jena Method in 2015, 306 patients received VA-ECMO treatment. Bacterial tests confirmed the sterility of the primed ECMO circuits during a 14-day period. The functionality of all the components of the primed ECMO circuit after 14 days, especially the pump and oxygenator, were thoroughly checked and no malfunction was found to this day. To train staff for independent ECMO initiation, a step-by-step system involves safely bringing the ECMO unit to the intervention site and establishing all connections. This includes powering up, managing recirculation, de-airing the system, and preparing it for cannula connection. A self-developed picture-based guide assists in this process. New staff members learn from colleagues and receive quarterly training sessions by perfusionists. After ECMO deployment, the perfusionist provides a new primed system for a potential next patient. Conclusions: Establishing a permanently wet-primed on-demand extracorporeal life support circuit without direct perfusionist support is feasible and safe. The Jena Method enables rapid ECMO deployment and has the potential to be adopted in emergency departments as well. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

4. Impact of a VA–ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock–Design and Rationale of the ECMOsorb Trial

Author

Haertel, Franz, primary, Lehmann, Thomas, additional, Heller, Tabitha, additional, Fritzenwanger, Michael, additional, Pfeifer, Ruediger, additional, Kretzschmar, Daniel, additional, Otto, Sylvia, additional, Bogoviku, Jurgen, additional, Westphal, Julian, additional, Bruening, Christiane, additional, Gecks, Thomas, additional, Kaluza, Mirko, additional, Moebius-Winkler, Sven, additional, and Schulze, P. Christian, additional

Published
2023
Full Text
View/download PDF

5. Effect of Hemolysis Regarding the Characterization and Prognostic Relevance of Neuron Specific Enolase (NSE) after Cardiopulmonary Resuscitation with Extracorporeal Circulation (eCPR)

Author

Haertel, Franz, primary, Babst, Josephine, additional, Bruening, Christiane, additional, Bogoviku, Jurgen, additional, Otto, Sylvia, additional, Fritzenwanger, Michael, additional, Gecks, Thomas, additional, Ebelt, Henning, additional, Moebius-Winkler, Sven, additional, Schulze, P. Christian, additional, and Pfeifer, Ruediger, additional

Published
2023
Full Text
View/download PDF

7. Rationale and Design of JenaMACS—Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock

Author

Haertel, Franz, primary, Lenk, Karsten, additional, Fritzenwanger, Michael, additional, Pfeifer, Ruediger, additional, Franz, Marcus, additional, Memisevic, Nedim, additional, Otto, Sylvia, additional, Lauer, Bernward, additional, Weingärtner, Oliver, additional, Kretzschmar, Daniel, additional, Dannberg, Gudrun, additional, Westphal, Julian, additional, Baez, Laura, additional, Bogoviku, Jurgen, additional, Schulze, P. Christian, additional, and Moebius-Winkler, Sven, additional

Published
2022
Full Text
View/download PDF

8. Rationale and Design of JenaMACS—Acute Hemodynamic Impact of Ventricular Unloading Using the Impella CP Assist Device in Patients with Cardiogenic Shock

Author

Haertel, Franz, Lenk, Karsten, Fritzenwanger, Michael, Pfeifer, Ruediger, Franz, Marcus, Memisevic, Nedim, Otto, Sylvia, Lauer, Bernward, Weingärtner, Oliver, Kretzschmar, Daniel, Dannberg, Gudrun, Westphal, Julian, Baez, Laura, Bogoviku, Jurgen, Schulze, P. Christian, Moebius-Winkler, Sven, Haertel, Franz, Lenk, Karsten, Fritzenwanger, Michael, Pfeifer, Ruediger, Franz, Marcus, Memisevic, Nedim, Otto, Sylvia, Lauer, Bernward, Weingärtner, Oliver, Kretzschmar, Daniel, Dannberg, Gudrun, Westphal, Julian, Baez, Laura, Bogoviku, Jurgen, Schulze, P. Christian, and Moebius-Winkler, Sven

Abstract

Introduction: Cardiogenic shock due to myocardial infarction or heart failure entails a reduction in end organ perfusion. Patients who cannot be stabilized with inotropes and who experience increasing circulatory failure are in need of an extracorporeal mechanical support system. Today, small, percutaneously implantable cardiac assist devices are available and might be a solution to reduce mortality and complications. A temporary, ventricular, continuous flow propeller pump using magnetic levitation (Impella®) has been approved for that purpose. Methods and Study Design: JenaMACS (Jena Mechanical Assist Circulatory Support) is a monocenter, proof-of-concept study to determine whether treatment with an Impella CP® leads to improvement of hemodynamic parameters in patients with cardiogenic shock requiring extracorporeal, hemodynamic support. The primary outcomes of JenaMACS are changes in hemodynamic parameters measured by pulmonary artery catheterization and changes in echocardiographic parameters of left and right heart function before and after Impella® implantation at different support levels after 24 h of support. Secondary outcome measures are hemodynamic and echocardiographic changes over time as well as clinical endpoints such as mortality or time to hemodynamic stabilization. Further, laboratory and clinical safety endpoints including severe bleeding, stroke, neurological outcome, peripheral ischemic complications and occurrence of sepsis will be assessed. JenaMACS addresses essential questions of extracorporeal, mechanical, cardiac support with an Impella CP® device in patients with cardiogenic shock. Knowledge of the acute and subacute hemodynamic and echocardiographic effects may help to optimize therapy and improve the outcome in those patients. Conclusion: The JenaMACS study will address essential questions of extracorporeal, mechanical, cardiac support with an Impella CP® assist device in patients with cardiogenic shock. Knowledge of the acute and subac

Published
2022

9. Relation of left atrial function with exercise capacity and muscle endurance in patients with heart failure

Author

Bekfani, Tarek, primary, Hamadanchi, Ali, additional, Ijuin, Shun, additional, Bekhite, Mohamed, additional, Nisser, Jenny, additional, Derlien, Steffen, additional, Westphal, Julian, additional, Bogoviku, Jurgen, additional, Morris, Daniel A., additional, Fudim, Marat, additional, Braun‐Dullaeus, Rüdiger C., additional, Möbius‐Winkler, Sven, additional, and Schulze, P. Christian, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results